CDC40 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.743000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.090200E-01
Normal-vs-Stage2
2.680000E-01
Normal-vs-Stage3
1.942220E-01
Normal-vs-Stage4
1.893410E-01
Stage1-vs-Stage2
4.319400E-01
Stage1-vs-Stage3
2.355000E-01
Stage1-vs-Stage4
8.844400E-01
Stage2-vs-Stage3
3.093000E-01
Stage2-vs-Stage4
6.482600E-01
Stage3-vs-Stage4
6.480300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.730400E-01
Normal-vs-AfricanAmerican
3.005200E-01
Normal-vs-Asian
1.610120E-02
Caucasian-vs-AfricanAmerican
1.507560E-01
Caucasian-vs-Asian
1.777570E-01
AfricanAmerican-vs-Asian
7.397800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.637600E-01
Normal-vs-Female
2.911200E-01
Male-vs-Female
3.646800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.802000E-01
Normal-vs-Age(41-60Yrs)
3.158600E-01
Normal-vs-Age(61-80Yrs)
2.595400E-01
Normal-vs-Age(81-100Yrs)
2.592000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.722000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.642400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.875800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.092950E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.288600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.198800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.338600E-01
Normal-vs-Daily Drinker
2.043400E-01
Normal-vs-Weekly Drinker
2.253000E-01
Normal-vs-Occasional Drinker
5.130000E-02
Normal-vs-Social Drinker
6.671800E-02
Non Drinker-vs-Daily Drinker
3.787400E-01
Non Drinker-vs-Weekly Drinker
7.910000E-01
Non Drinker-vs-Occasional Drinker
2.266400E-01
Non Drinker-vs-Social Drinker
2.746600E-01
Daily Drinker-vs-Weekly Drinker
6.331800E-01
Daily Drinker-vs-Occasional Drinker
8.045900E-02
Daily Drinker-vs-Social Drinker
1.261570E-01
Weekly Drinker-vs-Occasional Drinker
2.444400E-01
Weekly Drinker-vs-Social Drinker
2.866800E-01
Occasional Drinker-vs-Social Drinker
9.758400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.639600E-01
Normal-vs-Grade 2
2.255200E-01
Normal-vs-Grade 3
2.084600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.957800E-01
Grade 1-vs-Grade 3
5.314400E-01
Grade 1-vs-Grade 4
2.639600E-01
Grade 2-vs-Grade 3
8.615400E-01
Grade 2-vs-Grade 4
2.255200E-01
Grade 3-vs-Grade 4
2.084600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.548600E-01
Normal-vs-NonDiabetic
2.469400E-01
Diabetic-vs-NonDiabetic
8.306800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.892210E-01
Normal-vs-NoPancreatitis
2.607800E-01
Pancreatitis-vs-NoPancreatitis
4.236500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.996420E-02
Normal-vs-N1
2.683600E-01
N0-vs-N1
4.972600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.455000E-01
Normal-vs-TP53-NonMutant
8.531800E-02
TP53-Mutant-vs-TP53-NonMutant
5.219100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
